PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pulmonology, Erasmus Medical Center, Rotterdam, Netherlands.\', \'Department of Immunology, Erasmus Medical Center, Rotterdam, Netherlands.\', \'Department of Pulmonology, Amphia Hospital, Breda, Netherlands.\', \'Department of Biostatistics, Erasmus Medical Center, Rotterdam, Netherlands.\', \'Department of Intensive Care Medicine, Erasmus Medical Center, Rotterdam, Netherlands.\', \'Department of Clinical Chemistry and Hematology, Amphia Hospital, Breda, Netherlands.\', \'Department of Pathology, Erasmus Medical Center, Rotterdam, Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.684142
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34054876
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34054876>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34054876>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all